Crossmark

Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab

Crossref DOI link: https://doi.org/10.1007/s00467-018-4033-0

Published Online: 2018-08-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ağbaş, Ayşe https://orcid.org/0000-0002-3658-8622
Göknar, Nilüfer

Akıncı, Nurver

Yıldırım, Zeynep Yürük

Taşdemir, Mehmet

Benzer, Meryem

Gökçe, İbrahim

Candan, Cengiz

Küçük, Nuran

Uzuner, Selçuk

Özçelik, Gül

Demirkol, Demet

Sever, Lale

Çalışkan, Salim
License Information

Text and Data Mining valid from 2018-08-29
More Information

Article History

Received: 19 March 2018

Revised: 4 July 2018

Accepted: 23 July 2018

First Online: 29 August 2018

Compliance with ethical standards

:

: The study protocol was approved by the Ethics Committee of the Istanbul University, Cerrahpasa Medical Faculty. The study was conducted in accordance with the Declaration of Helsinki.

: The authors declare that they have no conflict of interest.